HRS-7085 / Jiangsu Hengrui Pharma - LARVOL DELTA

A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel Disease (clinicaltrials.gov) - P2 | N=30 | Not yet recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd.

New P2 trial • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Inflammatory Bowel Disease • Ulcerative Colitis

A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Phase I Clinical Trial Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Oral Doses of HRS-7085 Tablets in Healthy Subjects, With Assessment of Food Effects (clinicaltrials.gov) - P1 | N=70 | Not yet recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd.

New P1 trial • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Inflammatory Bowel Disease

A Trial of HRS-7085 Tablet in Healthy Participants With and Without Food Effect. (clinicaltrials.gov) - P1 | N=16 | Completed | Sponsor: Atridia Pty Ltd. | Recruiting ➔ Completed | N=42 ➔ 16

Enrollment change • Trial completion • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Inflammatory Bowel Disease

A Trial of HRS-7085 Tablet in Healthy Participants With and Without Food Effect. (clinicaltrials.gov) - P1 | N=42 | Recruiting | Sponsor: Atridia Pty Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Inflammatory Bowel Disease

A Trial of HRS-7085 Tablet in Healthy Participants With and Without Food Effect. (clinicaltrials.gov) - P1 | N=42 | Not yet recruiting | Sponsor: Atridia Pty Ltd.

New P1 trial • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Inflammatory Bowel Disease